FIELD: biochemistry.
SUBSTANCE: invention relates to an antibody-based composition having specific binding to interferon alpha 1 (IFNAR1) receptor.
EFFECT: invention provides effective treatment of diseases associated with interferon alpha 1 (IFNAR1) receptor.
13 cl, 5 dwg, 10 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE AQUEOUS COMPOSITIONS BASED ON ANTIBODIES | 2014 |
|
RU2763787C2 |
| COMPOSITIONS OF ANTIBODIES TO RSV AND METHODS OF THEIR APPLICATION | 2019 |
|
RU2807524C2 |
| ANTIBODY COMPOSITION | 2015 |
|
RU2743681C2 |
| PHARMACEUTICAL FORMULA CONTAINING HUMAN ANTI-TSLP ANTIBODY | 2016 |
|
RU2794148C2 |
| COMBINED FORMULATIONS OF ANTI-LAG3 ANTIBODY AND ANTI-PD-1 ANTIBODY | 2019 |
|
RU2822192C2 |
| ANTIBODY FORMULATIONS | 2017 |
|
RU2769326C2 |
| STABILISED COMPOISITONS, CONTAINING ANTIBODIES TO INTERLEUKINE 6 (IL-6R) RECEPTOR | 2011 |
|
RU2554779C2 |
| STABLE BINDING PREPARATIONS BASED ON IgG4 | 2013 |
|
RU2644214C2 |
| COMPOSITIONS OF ANTIBODIES | 2014 |
|
RU2694055C2 |
| FORMULATION FOR BISPECIFIC T-CELL ENGAGERS (BITES) | 2013 |
|
RU2679124C2 |
Authors
Dates
2020-09-08—Published
2016-08-18—Filed